Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunosuppressants for nonspecific interstitial pneumonia
ChiCTR1900027121Phase 4Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Oct 2019
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of mycophenolate mofetil, tacrolimus and cyclophosphamide in idiopathic nonspecific interstitial pneumonia (NSIP) (4 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Forced vital capacity. Started Oct 2019; status: recruiting.
02
Drugs
mycophenolate mofetiltacrolimuscyclophosphamide
03
Conditions
idiopathic nonspecific interstitial pneumonia (NSIP)
Beyond the preview
Go deeper on ChiCTR1900027121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027121.